GPGerry Polton

Gerry Polton

*This is an algorithmically generated author record based on publicly available information.

Gerry Polton has a total of 211 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Diagnosis and surgical management of an extraskeletal osteosarcoma of the brachial plexus in a Belgian shepherd dog

    by Z. R. Nalborczyk, E. Hall, R. Cappello, G. Polton, A. Groth

    An 11‐year‐old Belgian shepherd presented with progressive right thoracic limb lameness. Computed tomography and magnetic resonance imaging revealed a brachial plexus neoplasm and cytology was suggestive of a sarcoma. The patient underwent forequarter amputation and hemilaminectomy of the fifth cervical to first thoracic vertebrae with nerve root transection. Histopathology confirmed extraskeletal osteosarcoma. Twelve months post‐operatively, the dog was exercising normally, and computed tomography did not identify local recurrence or metastatic disease. This is the first recorded case of canine brachial plexus extraskeletal osteosarcoma.


  • Patterns of nodal metastases, biological behaviour and prognosis of canine mast cell tumours of the pinna: A multi‐institutional retrospective study

    by Carmit Chalfon, Riccardo Finotello, Silvia Sabattini, Irina Gramer, Joanna Siriol Morris, Marina Aralla, Emanuela Maria Morello, Erica Ferraris, Sofia Ramos, Gerry Polton, et al.

    Canine cutaneous mast cell tumours (cMCTs) of the pinna have been associated with an aggressive biological behaviour, although data remain scarce. The knowledge acquired over the past years on histologic gradings, and the value of lymph node (LN) staging, may help in better characterizing this anatomical presentation. The first aim was to describe the frequency, location, and histologic appearance of LN metastases in cMCT of the pinna. A second aim was to evaluate prognosis. Medical records of dogs with cMCT of the pinna, that underwent tumour and sentinel (SLN) or regional LN (RLN) excision, were reviewed. The influence of potential prognostic variables on time to progression (TTP) and tumour‐specific survival (TSS) was investigated. Thirty‐nine dogs were included: 19 (48.7%) had Kiupel high‐grade (K‐HG) and 20 (51.3%) had low‐grade (K‐LG) MCTs. Eighteen (46.1%) dogs underwent SLN mapping: the superficial cervical LN was at least one of SLN in 17 (94.4%) cases. Twenty‐two (56.4%) dogs had LN metastases; the superficial cervical LN was always involved. On multivariable analysis, only K‐HG was associated with increased risk of progression (p = .043) and tumour‐related death (p = .021). Median TTP and TSS were 270 and 370 days in K‐HG, respectively; these were not reached in dogs with K‐LG tumours (p < .01). cMCTs of the pinna are often K‐HG and are also associated with a higher frequency of LN metastasis; however, we confirmed the independent prognostic value of histologic grading. A multimodal treatment may lead to favourable long‐term outcome. Moreover, the superficial cervical LN is most often the SLN.


  • Isotretinoin treatment of 12 dogs with epitheliotropic lymphoma

    by Sofia Chichorro Ramos, Michael John Macfarlane, Gerry Polton

    Background Epitheliotropic lymphoma is an uncommon cutaneous malignancy of T lymphocytes. Limited information is available regarding the treatment and outcome of dogs with this disease. Objectives To evaluate the treatment outcome and toxicity profile of isotretinoin in dogs with epitheliotropic lymphoma. Animals Twelve dogs with a diagnosis of epitheliotropic lymphoma were included. Materials and methods A medical database was searched for dogs diagnosed with epitheliotropic lymphoma and treated with isotretinoin between 2010 and 2021. Diagnosis, treatment details and tumour response were recorded for 12 dogs. Results All lesions resolved in four of 12 (33%) treated dogs. Lesions visibly improved in a further three dogs, giving a response rate of 58%. Two dogs' lesions remained unchanged and three progressed despite therapy. Adverse effects occurred in three dogs (25%), all of which were rapidly resolving or not affecting quality of life. Conclusion Isotretinoin treatment was a well-tolerated and effective treatment for canine epitheliotropic lymphoma.


  • Mast cell tumours in dogs less than 12 months of age: a multi‐institutional retrospective study

    by K. Rigas, D. Biasoli, G. Polton, R. Finotello, S. Murphy, S. Di Palma, M. Starkey, S. Verganti

    Objectives: To describe the clinicopathological and genetic characteristics of mast cell tumours in dogs less than 12 months old.Materials and Methods: Retrospective review of dogs aged less than 12 months when diagnosed with mast cell tumours at three referral hospitals in the UK.Results: Sixteen pure‐bred dogs were included, of which 11 were female. The median age at first presentation and diagnosis were 7.6 and 9 months, respectively. In 13 dogs the mast cell tumours were cutaneous and in three they were subcutaneous. Four cutaneous mast cell tumours were described as high‐grade (Patnaik or Kiupel) and nine were Patnaik grade II; three had mitotic index of >5 in 10 high‐power fields. Of the three subcutaneous tumours, two had an infiltrative growth pattern and one had mitotic index of 10per10 high‐power fields. Of 10 tested dogs, seven had c‐kit mutations in exon 11 and Ki‐67 score was above the cut‐off value in nine. Four of 12 cases showed evidence of metastasis in the regional lymph nodes. After varying treatment protocols, all patients were alive and disease free at a median of 1115 days after diagnosis.Clinical Significance: The prognosis of mast cell tumours in dogs less than a year old appears better than the adult counterparts, even without extensive treatment.


  • Genicular artery axial pattern flap for reconstruction of skin defects in 22 dogs

    by T. Emmerson, B. de la Puerta, G. Polton

    Objective: To report the use of the genicular artery axial pattern flap and the frequency and severity of complications in a consecutive series of clinical cases.Materials and Methods: Medical records from one referral centre were retrospectively reviewed for cases requiring reconstruction using a genicular axial pattern flap between January 2012 and February 2018.Results: Twenty‐two dogs were included. Skin defects ranging from 12.6 to 81 cm2(mean 32 cm2) on the lateral and cranial crus were successfully closed using the genicular artery axial pattern flap. Average flap survival was 99.1% with two dogs developing distal flap necrosis. Minor complications occurred in eight dogs (36%) including minor wound dehiscence, seroma formation and infection. Major complications requiring further surgery occurred in three dogs (13.6%).Clinical Significance: The genicular artery axial pattern flap is useful in the reconstruction of small‐ to medium‐sized skin defects of the lateral and cranial crus. The flap may be more robust and offer better viability than reported previously in experimental studies.


  • Open Access

    Evaluation of the histopathological extent of neoplastic infiltration in intestinal tumours in cats

    by Michael Morrice, Gerry Polton, Sam Beck

    With the exception of intestinal lymphoma, surgery is the most commonly recommended treatment for solitary feline intestinal tumours. However, there is a lack of evidence to substantiate resection margin recommendations for these tumours. The aim of this study was to add knowledge concerning resection margins for discrete intestinal masses in cats. Thirty confirmed feline intestinal tumours removed at veterinary centres across theUKfrom March 2017 to March 2018 underwent histological assessment at the palpable edge of the intestinal tumour and then at every 1 cm increment to the surgeon‐cut tissue border in oral, aboral and mesenteric directions. Histological margin recommendations were developed for carcinoma and lymphoma tumour types and non‐lymphoma intestinal tumours collectively. Seventeen intestinal lymphomas, nine carcinomas, two sarcomas and two mast cell tumours were evaluated in this study. Seven of the nine intestinal carcinomas would have been completely removed with histological margins of 4 cm in oral and aboral directions. Both sarcomas and one mast cell tumour would have been removed in their entirety with 4 cm histological margins in oral and aboral directions. There was extensive and varied microscopic invasion of intestinal tissue away from discrete intestinal lymphomas in the majority of the cases in this study. There is increasing evidence in veterinary as well as human literature supporting the role of surgical resection in the treatment of discrete intestinal lymphoma. If surgery is to be considered this study supports the removal of the gross tumour only. A histological margin of 4 cm should be considered, where possible, for intestinal masses other than lymphomas.


  • Open Access

    Phenotypic and transcriptomic characterization of canine myeloid-derived suppressor cells

    by Michelle R. Goulart, Sabina I. Hlavaty, Yu-Mei Chang, Gerry Polton, Anneliese Stell, James Perry, Ying Wu, Eshita Sharma, John Broxholme, Avery C. Lee, et al.

    Myeloid-derived suppressor cells (MDSCs) are key players in immune evasion, tumor progression and metastasis. MDSCs accumulate under various pathological states and fall into two functionally and phenotypically distinct subsets that have been identified in humans and mice: polymorphonuclear (PMN)-MDSCs and monocytic (M)-MDSCs. As dogs are an excellent model for human tumor development and progression, we set out to identify PMN-MDSCs and M-MDSCs in clinical canine oncology patients. Canine hypodense MHC class II−CD5−CD21−CD11b+ cells can be subdivided into polymorphonuclear (CADO48A+CD14−) and monocytic (CADO48A−CD14+) MDSC subsets. The transcriptomic signatures of PMN-MDSCs and M-MDSCs are distinct, and moreover reveal a statistically significant similarity between canine and previously published human PMN-MDSC gene expression patterns. As in humans, peripheral blood frequencies of canine PMN-MDSCs and M-MDSCs are significantly higher in dogs with cancer compared to healthy control dogs (PMN-MDSCs: p < 0.001; M-MDSCs: p < 0.01). By leveraging the power of evolution, we also identified additional conserved genes in PMN-MDSCs of multiple species that may play a role in MDSC function. Our findings therefore validate the dog as a model for studying MDSCs in the context of cancer.


  • Open Access

    Evaluation of the extent of neoplastic infiltration in small intestinal tumours in dogs

    by Michael Morrice, Gerry Polton, Sam Beck

    There is currently a lack of evidence‐based guidance when determining surgical margins for small intestinal tumours in dogs. The purpose of this study is to help the surgeon make informed clinical decisions about margins when confronted with a small intestinal mass. Twenty‐seven canine small intestinal tumours were histologically diagnosed and then had further histological assessment at every centimeter from the edge of the palpable tumour to the surgical margin in oral, aboral and mesenteric directions. In all 10 carcinomas a 3 cm tissue margin in oral, aboral and mesenteric directions would have resulted in complete tumour resection. In all 11 sarcomas a 2 cm tissue margin in oral, aboral and mesenteric directions would have resulted in complete tumour resection. Five of the six intestinal lymphomas would have required tissue margins of 4 cm or more for complete resection. Of the 21 non‐lymphoma tumours assessed in this study, complete resection was achieved in all 21 (100%) with tissue margins at 3 cm from the palpable edge of the mass, 20 (95%) with tissue margins at 2 cm from the palpable edge of the mass, and 16 (76%) with tissue margins at 1 cm from the palpable edge of the mass in oral and aboral directions. All non‐lymphoma canine small intestinal masses will be completely resected when tissue margins are 3 cm from the palpable edge of the mass in oral and aboral directions after fixation in formalin.


  • Diagnosis of anaplastic large-cell lymphoma in a dog using CD30 immunohistochemistry

    by Rachel Pittaway, Ying Wu, Balazs Szladovits, Alejandro Suárez-Bonnet, Emma J. Scurrell, Oliver A. Garden, Gerry Polton, Simon L. Priestnall

    Anaplastic large-cell lymphoma or null-cell lymphoma is a clinical entity reported in people, classified according to the unique appearance of large pleomorphic cells that express CD30. Null-cell lymphoma has also been described in dogs when neither CD3 nor CD79α is expressed by the tumor. We describe a case of lymphoma in the dog in which neoplastic cells did not express routine B- or T-lymphocyte markers on flow cytometry or immunohistochemistry; however, cells immunohistochemically labeled for CD30. The dog in our case died 5 mo after initial presentation, confirming a poor prognosis. Identification of further similar cases in dogs would provide additional prognostic information for this subset of lymphomas. CD30 may also serve as a potential therapeutic target in anaplastic large-cell lymphomas.


  • Cover Image, Volume 15, Issue 1

    by E. Treggiari, L. Ressel, G. A. Polton, J. Benoit, I. Desmas, L. Blackwood